Non-clinical studies indicating lack of interactions between iron/calcium ions and linzagolix, an orally available GnRH antagonist.
ADME
DDI
GnRH antagonist
Linzagolix
calcium ion
iron ion
Journal
Xenobiotica; the fate of foreign compounds in biological systems
ISSN: 1366-5928
Titre abrégé: Xenobiotica
Pays: England
ID NLM: 1306665
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
pubmed:
2
8
2022
medline:
31
8
2022
entrez:
1
8
2022
Statut:
ppublish
Résumé
Linzagolix is an orally available gonadotropin-releasing hormone antagonist used to treat sex-hormone-dependent diseases in women. This study aimed to investigate drug-drug interactions between linzagolix and iron/calcium ions in the intended clinical setting by conducting pharmacokinetic studies
Identifiants
pubmed: 35913106
doi: 10.1080/00498254.2022.2109076
doi:
Substances chimiques
Carboxylic Acids
0
Ions
0
Pyrimidines
0
Gonadotropin-Releasing Hormone
33515-09-2
linzagolix
7CDW97HUEX
Iron
E1UOL152H7
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM